Rhodiola belongs to the family Crassulaceae and found in high-altitude areas of Asia, Europe, and Northern Hemisphere. Several Rhodiola species are widely exploited in traditional remedies and showed an enormous number of pharmacological properties. Phytochemical research of Rhodiola spp. revealed the existence of numerous phytoconstituents like phenols, flavonoids, alkaloids, glycosides, diterpenes, and triterpenes. The pharmacologically important bioactive components of Rhodiola spp. are rosin, tyrosol, rosarin, rhodionin, catechin, salidroside, and gallic acid. Traditionally, Rhodiola plants are exploited as anti-inflammatory, adaptogens, anti-stress, and remedies. Moreover, this plant is being valued for its extensive number of pharmaceutical applications like cardioprotective, anti-fatigue, antioxidant, neuroprotective, anti-hypoxia, anti-cancer, anti-stress, and anti-inflammatory activities. Therefore, Rhodiola spp. can be appraised as a promising therapeutic approach against fatal immunosuppressive with negligible side effects. This review article summarizes the phytochemical, pharmacological, toxicological, clinical studies, cultivation, and conservation of Rhodiola species including R. imbricata, R. crenulata, R. tibetica, and R. heterodonta.Keywords
Rhodiola
PhytochemistrySalidrosidePharmacologyToxicology